This increased OX-LDL in the pathogenesis of CLD is consistent with our transcriptional data from LECs from livers of people with NASH, in that pathways involved in free radical scavenging, IL13 signaling and genes involved in cholesterol sensing were upregulated (Tamburini et al., 2019). Here, IL13 is linked to metabolic dysfunction-associated steatohepatitis.